01 January 1998
Comparative assessment of 200/0.5 HAES 6% and Gelafundin in the treatment of hypovolaemia in post-coronary bypass patients
Beata Dytkowska, Zbigniew Karwacki, Janina Suchorzewska, Maria WujtewiczMed Sci Monit 1998; 4(6): CR1000-1003 :: ID: 451758
Abstract
40 patients after operations of coronary bypass in extracorporeal circulation were examined in order to evaluate usefulness of 200/0.5 HAES 6% and Gelafundin. The patients were divided into 2 groups, depending on received drug (group I - HAES, group 2 - Gelafundin). A single dose of up to 15 ml/kg b. m. of colloids was given to patients with diagnosed symptoms of hypovolaemia, haematocrit values over 30%. The following parameters were investigated: systolic, diastolic, mean arterial blood pressure, measured directly, as well as central venous pressure (CVP). The measurements were taken before the onset of infusion, as well as in 15, 30, 45, 60 minute of infusion and 15, 30 minutes after its completion. Biochemical parameters such as haemoglobin, haematocrit, number of platelets, albumin concentration, osmolality and selected blood clotting parameters were investigated before as well as 30 minutes after administration of the drugs. At the end of drug infusion, both groups demonstrated statistically significant increase of systolic and mean arterial blood pressure as well as central venous pressure. No significant effect of administered colloids upon biochemical parameters was
observed. Both HAES and Gelafundin were well tolerated by the patients. No allergic reactions were observed either during infusion or after its completion.
key words: coronary bypass • postoperative treatment • hypovolaemia
Keywords: coronary bypass, postoperative treatment, hypovolaemia
Editorial
01 January 2026 : Editorial
Editorial: Increasing Awareness of Lung Cancer in Non-Smokers and Never-Smokers Challenges Current Approaches to Prevention and ScreeningDOI: 10.12659/MSM.952454
Med Sci Monit 2026; 32:e952454
In Press
Clinical Research
Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...Med Sci Monit In Press; DOI: 10.12659/MSM.951027
Clinical Research
Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...Med Sci Monit In Press; DOI: 10.12659/MSM.950516
Review article
Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.951283
Clinical Research
Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 AdultsMed Sci Monit In Press; DOI: 10.12659/MSM.950938
Most Viewed Current Articles
17 Jan 2024 : Review article 10,187,196
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
13 Nov 2021 : Clinical Research 3,708,487
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
14 Dec 2022 : Clinical Research 2,341,643
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 706,524
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387






